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Abstract
Etiologic diagnoses of lower respiratory tract infections (LRTI) have been relying primarily on bacterial cultures that often fail
to return useful results in time. Although DNA-based assays are more sensitive than bacterial cultures in detecting
pathogens, the molecular results are often inconsistent and challenged by doubts on false positives, such as those due to
system- and environment-derived contaminations. Here we report a nationwide cohort study on 2986 suspected LRTI
patients across P. R. China. We compared the performance of a DNA-based assay qLAMP (quantitative Loop-mediated
isothermal AMPlification) with that of standard bacterial cultures in detecting a panel of eight common respiratory bacterial
pathogens from sputum samples. Our qLAMP assay detects the panel of pathogens in 1047(69.28%) patients from 1533
qualified patients at the end. We found that the bacterial titer quantified based on qLAMP is a predictor of probability that
the bacterium in the sample can be detected in culture assay. The relatedness of the two assays fits a logistic regression
curve. We used a piecewise linear function to define breakpoints where latent pathogen abruptly change its competitive
relationship with others in the panel. These breakpoints, where pathogens start to propagate abnormally, are used as
cutoffs to eliminate the influence of contaminations from normal flora. With help of the cutoffs derived from statistical
analysis, we are able to identify causative pathogens in 750 (48.92%) patients from qualified patients. In conclusion, qLAMP
is a reliable method in quantifying bacterial titer. Despite the fact that there are always latent bacteria contaminated in
sputum samples, we can identify causative pathogens based on cutoffs derived from statistical analysis of competitive
relationship.
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Introduction
Lower respiratory tract infections (LRTI) represent a major
public health problem, accounting for 12% and 16% of inpatient
hospitalization in urban and rural hospitals, respectively, in the
People’s Republic of China. [1] Since traditional bacterial cultures
for etiologic diagnoses of LRTI take at least 48 to72 hrs to
complete and frequently produce false-negative results, the
treatment of LRTI is often imprecise, and mistreatment contrib-
utes significantly to antibiotic misuse and overuse. [2,3].
DNA- based methods (including indirectly for RNA) have been
successfully applied in single or multiple pathogen detection,
including those for TB, CMV, HIV, Pneumocystis jirovecii, etc. [4,5]
However, DNA-based methods for the identification of causative
pathogens in sputa as routine diagnoses of LRTI have been
hampered by inconsistent results with culture-based methods.[6–
8] Discrepancies between the two methods have to be thoroughly
explained before DNA-based methods can be routinely applied in
LRTI diagnosis. Here, we report an application of a DNA-based
assay– qLAMP (quantitative Loop-mediated isothermal AMPlifi-
cation) [9] –in the detection of a panel of eight common bacterial
pathogens in sputa of LRTI patients and provide an evaluation on
the reliability of qLAMP in a close comparison to culture-based
assays.
Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
Patients
The suspected LRTI patients diagnosed by physicians in 21
tertiary hospitals in 14 provinces of the People’s Republic of China
(Figure S1) were consecutively enrolled in this study. They were
initially diagnosed as suspected cases for bacterial LRTI, having
typical characteristics of pneumonia or bronchitis, which were
firmly inferred from chest X-rays and one of the following criteria:
(1) fever.38.5uC, (2) peripheral white blood cell count
(WBC).10.0610
9/L and neutrophil % .60%, (3) exacerbated
dyspnea, and (4) exacerbated sputum production or purulence.
Patients diagnosed with non-infectious diseases or infection by
non-bacterial pathogens (including viruses, fungi, and pneumocystis)
or TB were subsequently excluded from the cohort.
The study was approved by the Institutional Review Board of
Peking University People’s Hospital and registered at www.
clinicaltrial.gov (registration ID: NCT00567827). Written consent
was obtained from all patients prior to recruitment. All
participating researchers were trained thoroughly on patient
enrollment, sample collection, and clinical information entry.
Sample and Information Collection
From each enrolled patient, we collected four spontaneous
early-morning sputa: two samples on the 1st day and one each on
the 2nd and 3rd days of post-admission. One 1
st-day sputum
sample was evaluated using light microscopy (WBC $25 and
epithelia cells ,10 per 1006field), and qualified sputa (50% broth
glycerol added) were transported to the central laboratories at
Peking University People’s Hospital on dry ice and used for
routine culture and qLAMP assays. The other three collections
were subjected to routine culturing and identification (VITEK2
system, bioMe ´rieux Inc, France) at the local hospitals. In some
cases involving toddlers or infants, sputa or BALF samples were
obtained using fiberoptic bronchoscopy (performed according to
clinical requirements) (See Figure 1). We also collected clinical
data, including demographic features, diagnoses, results of culture
assays, antibiotic treatments, treatment outcomes, and lengths of
hospital stays, and entered the information into a customized
database.
Laboratory Methods
For each patient, we carried out a parallel study using both
routine culture-based and qLAMP assays. Each sputum sample
was liquefied in equal volume of 10% NaOH, and DNA was
isolated by using the Universal Kit for Bacterial DNA Extraction
(Capitalbio Corporation, P. R. China). We designed PCR primers
for the eight bacterial pathogens based on genomic sequences
retrieved from Genebank (Table S1), and they are: Acinetobacter
baumannii, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae,
Pseudomonas aeruginosa, Staphylococcus aureus, Stenotrophomonas maltophi-
lia and Streptococcus pneumoniae. Each primer set was designed based
on a previously-described strategy (Table S2 and Figure S2).
[10,11] Sensitivity, specificity, and reproducibility of the primers
were evaluated based on quantified DNA from 27 bacterial species
(Table S3). qLAMP was performed based on a real-time
fluorescence detection method. [12] The titer was quantified
according to standard curves obtained from pre-quantified DNA
templates (Methods S1) as copy number per milliliter sputum.
Two experienced technicians who were not aware of the sample
identities conducted the qLAMP tests and routine cultures
independently in two separate laboratories (the central laborato-
ries) at the Peking University People’s Hospital.
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Evaluating the robustness of qLAMP assay. To evaluate
the congruence of qLAMP and culture results, we constructed a
contingency table and used Fisher’s exact and chi-square tests. For
each pathogen, we estimated the probability of being positive in
culture as a function of the titer quantified in qLAMP in terms of
logistic regression (Methods S1).
Determining cutoffs for the pathogen panel. For each
patient, species X is a ‘‘pathogen candidate’’ (PC) if it has the
maximal titer within the panel, and then the probability of being PC
(P-PC) represents the relative competitive potency of the species.
Given the fact that there are errors in empirical quantification and
possibilities of mixed infection, species with a titer near maximum
in the panel is also regarded as PC if its difference to maximum is
less than 0.5 in logarithmic scale. Since all bacterial species in the
panel also dwell in airways of healthy persons or patients in a
latent period, we are able to assume that they may experience
three similar stages in becoming pathogenic: lag phase (being
latent within the microflora), log phase (being competitive to other
species when propagates abnormally), and dominant phase (being
pathogenic when dominates in the microflora). By using piecewise
linear regression in 1–3 fold zig-lines, we estimated P-PC or the
probability of a bacterium to become a pathogen candidate as a
function of the titer or bacterial load for each species. In the linear
regression chart, the breakpoints between segments are what we
call cutoffs that lie either between normal flora and potential
pathogens–the lower cutoff, or between potential pathogens and
definite pathogens–the upper cutoff. For species that did not
converge well, we stratified all qualified patients based on their
clinical records and medical knowledge.
Results
Data from Sputum Cultures
We obtained raw data from 1533 inpatients out of 2986 eligible
candidates qualified for the final analysis, based on samples
collected from December 2007 to June 2009 (Figure 1). We
summarized patient information including hospitals, demographic
characteristics, and LRTI diagnoses in Tables S4 and S5. In
culture assay, although we found 43 bacterial species and 17 fungi
species in total, only the eight species in the pathogen panel are
taken into account. For culture assays done in the central
laboratories (one-time culture), we have 100 cases (6.52%) tested
positive for at least one of the panel members, and for the culture
done in local hospitals (three-time culture), we have 266 cases
(17.35%) tested positive for at least one of the panel members in at
least one of the three-time cultures (Figure 2). For each species, the
average confirmation rates among all cultures (four times
altogether: one done in the central laboratory and three done in
local hospitals) range from 0.17 to 0.50 (Table 1). In other words,
it is impossible to detect the same species of bacteria in a sputum
sample in all repeated culture assays. The qLAMP and culture
results from the central laboratories were never communicated to
local hospitals, and the strategies of anti-infectious treatments are
only based on the culture results obtained independently. No
adverse effects are found either being caused by the protocols or as
results of performing qLAMP and routine culture assays on
patients during the study.
Data from qLAMP Assays
We optimized the primers to reach a sensitivity of 10
3 copies/ml
targeted DNA in sputa and high specificity that no detectable
cross-reactions with control DNA from 26 other species of bacteria
were found (Methods S1). For the clinical sputum data, we
compared the qLAMP results to those of the cultures, and found
that qLAMP assay is 2–11 times more sensitive when compared to
the culture assays (three-time culture) (Figure 2A). In a total of
1062 patients (69.28% from all 1533 qualified patients), we
detected at least one species positive in qLAMP; this result leads to
sensitivities of 10.6 times when compared to those of the one-time
culture and 4 times to those of the three-time culture (Figure 2B).
Even though qLAMP is more sensitive than culture, we still have
0.6–2.8% of the positive cases suggested by the culture results but
are unable to confirm them via qLAMP (Table 1).
Relatedness between qLAMP and Culture Assays
We assess the relatedness between the two assays based on
contingency table and logistical regression curve. For this part of
the analysis, we only used the culture results from local hospitals,
since there are variable bacterial mortalities (ranged 0–1 and
averaged 0.604) detected in the central laboratories, largely due to
refrigeration during the sample storage and transport periods. We
made two observations. First, we noticed that the p values in
contingency table, which evaluates independence between
qLAMP and culture data, are extremely low overall. This suggests
that the titers quantified via qLAMP are not stochastic and have a
strong correlation to culture results (Table 2). Second, when we
look at logistical regression for each bacterium, the probability of
being positive in culture and the titer quantified via qLAMP fit
logistical regression curves (Figure S3). As an example, we show a
result of logistic regression for S. pneumoniae in Figure 3 A. The p
values of logistic regression are all extremely low (Table 2) except
for H. influenzae (p value 0.0115.0.01), mainly due to its fragility
and low positive rate in culture. The strong correlations between
the two methods based on the results of contingency table and
logistic regression demonstrate the robustness of qLAMP assay.
Although the qLAMP method is more sensitive than the
culture-based method, there are exceptional cases of positive
results in culture that are not confirmed by qLAMP. However,
these cases can also be explained by the relatedness between the
two methods in term of logistical regression. When the titer or
presence of the panel members is actually lower than the qLAMP
detection limit of 10
3 copies/ml, it is still possible that these
exceptional positive cases in culture are contributed by several
viable bacterial cells in samples that have a very low possibility or
even can never be detected via qLAMP. When deducing the
logistic regression curve to titer range below 10
3 copies/ml,
positive rate of culture can be estimated by calculation based on
regression function, and our confidence is supported by the fact
that the observed positive rate of culture assays is always lower
than the estimated rate when titers are over-estimated as normal
distribution within the range (Table 2).
The Probability of being Pathogen Candidates (PC) and
Deduced Cutoffs
When choosing piecewise linear regression to analyze our data,
we found that for some species in the panel the curves converge
Figure 1. A flow chart of patient recruitment and sample processing. After admission, we collected 4 sputum samples from each patient.
The same samples are used for the parallel qLAMP and culture tests. The results from qLAMP and one-time culture are from the same sample, and
those of qLAMP and three-time culture are from the same patient, but not the same sample.
doi:10.1371/journal.pone.0038743.g001
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the panel the curves only converge when patients are stratified in
subgroups (cutoffs see Table 2, regression curves for each species
see Figure S4). In the results from H. influenzae, K. pneumoniae, P.
aeruginosa, S. maltophilia, and S. pneumoniae, we observed that
covariates often play an important role, which can lead to
different cutoffs in different subgroups, and that strategies of
stratification based on medical knowledge improve convergence
significantly. An example of S. pneumoniae in adult patients with
COPD (chronic obstructive pulmonary disease) is shown in
Figure 3B. The zig-like curve shows the probability of being PC
(or competitive potency) for a bacterium that often experiences lag,
Figure 2. qLAMP and culture result from LRTI patients. (A) The positive rates (the right vertical axis) of one-time culture (brown bar), three-
time culture (blue bar), and quantitative LAMP (yellow bar) for the eight species in the panel (from the left: Ab, A. baumannii; Ec, E. coli; Hi, H.
influenzae; Kp, K. pneumoniae; Pa, P. aeruginosa; Sa, S. aureus; Sm, S. maltophilia; and Sp, S. pneumoniae) detected from the number of patients (the
left vertical axis). (B) The number of patients (the left vertical axis) who were tested positive for at least one bacterium in one-time culture, three-time
culture, and qLAMP. Each bar is the sum of patient with single (blue bar) and multiple (yellow bar) species detected.
doi:10.1371/journal.pone.0038743.g002
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pathogenic status.
In a list of cutoffs derived from piecewise linear regression, there
is a decrease in cutoff values for pathogens defined in subgroups of
susceptible patients and such a decrease means that bacteria gain
competitive advantages more easily in these patients (Table S6).
For example, the cutoffs for P. aeruginosa are lower in the
bronchiectasis patients than in other patients. Similarly, the cutoffs
for S. pneumoniae in children are as low as the qLAMP detection
limit, but rise to 1.62610
5 and 2.28610
7 copies/ml in adult
patients without COPD. These results are in agreement with
general clinical experiences and the literature. [13,14].
Epidemiologic Analysis Based on qLAMP Data
Based on titers quantified from qLAMP and cutoffs deduced
from piecewise linear regression, we are able to identify the
causative (definite or potential) pathogens for each patient
subgroup (Figure 4). First, the major pathogens are S. pneumoniae
(16.31%) in children and P. aeruginosa (37.04%) in AEBX (acute
exacerbation of bronchiectasis) patients. Second, the fraction of
infections from A. baumannii, E. coli, S. aureus, and S. maltophilia
appears to increase together with age in all patients. Third, the
diagnostic rates for single and mixed infections are 32.55% and
16.37%, respectively, making a total of 48.92%. Fourth, the
diagnosis rates of total and mixed infections increase with age and
the severity of infections (Figure 5). These results are also
essentially in accordance with previous epidemiological studies.
[15,16].
Discussion
Quantitative LAMP is a Potential Diagnostic Tool for LRTI
DNA-based pathogen detection is becoming increasingly
popular in recent years. More quantitative methods, such as
real-time PCR and branch-DNA, provide adequate sensitivity for
detecting even single copy of targeted DNA sequences and are
thus capable of reaching nearly 100% specificity when used on the
identification of standard pathogen strains. [17] LAMP represents
a novel method in the same category that uses a single incubation
temperature. It eliminates the need for expensive thermal cyclers,
and has been applied in pathogen detection of infectious diseases,
such as tuberculosis and malaria. [18,19] It can be quantitative in
that it measures turbidity or fluorescent signals from labeled DNA
with similar sensitivity and specificity as real-time PCR. [20]
Although quantitative LAMP (qLAMP) is more expensive than
routine bacterial culture, the gross cost of the test is easily
compensated by its ability to inform more accurate and timely
etiological diagnosis. Therefore, qLAMP, or even other DNA-
based methods, should have significant impacts on the etiological
diagnosis for LRTI so long as these tests have acceptable sensitivity
and specificity.
As all DNA-based methods do, qLAMP also has its potential
drawbacks, such as the effect of sequence mutations on sensitivity
and accuracy. In order to minimize this effect, we have
deliberately selected the most characteristic and conservative
genes as target sequences. However, it is still possible that clinical
strains harbor mutations on the sequences where primers are
designed. Fortunately, qLAMP is less affected by mutations than
other methods, such as real-time PCR, for its long primers that
cover over 160 bp in length. One or two mutations often do not
make distinguishable effects on amplification. In our experience,
only G/CRA mutations at the 39 end of the most important
primer–BIP or FIP–can lead to quantity undervaluation and lower
sensitivity. However, our data show that the qLAMP method is
much more sensitive than culture-based method. Therefore, the
effect of mutations can not be a prevalent factor that influences the
accuracy of qLAMP. Given the situation in our study, i.e., about
40% variations (changes at sites where primers are designed) in all
sequenced strains and average 3.3 mutations in each mutant, the
theoretical incidence of the effective mutation is only less than
0.5% in all strains. In addition, qLAMP has been successfully
utilized in quantitative assays for many bacterial species and even
viruses in clinical samples, [21,22] while there has not been
creditable evidence to suggest that qLAMP is very sensitive to
sequence mutations of its targets in real cases.
Could We Explain Discrepancies between DNA- and
Culture-based Methods?
The clinical application of DNA-based methods in detecting
bacteria has long been hampered by the discrepancies between
their results and those from culture-based methods–most popular
Table 1. Data Summary of qLAMP and culture assays.
Ab Ec Hi Kp Pa Sa Sm Sp
qLAMP + 2 + 2 + 2 + 2 + 2 + 2 + 2 + 2
220 1313 102 1431 194 1339 244 1289 200 1333 140 1393 227 1306 190 1343
Total Culture 25 33 14 24 6 12 34 26 58 39 28 25 10 11 27 21
Three-time Culture 23 30 10 21 6 12 21 22 55 38 12 18 9 8 15 18
One-time Culture 6 5 7 4 0 0 22 5 3 1 24 7 3 3 16 3
Confirmed
Culture*
98 75 10 1 2 4 1 6 1 2 82 20 60
Confirmation
rate**
0.36 0.24 0.5 0.208 0.17 0.00 0.35 0.154 0.27 0.307 0.285 0.08 0.2 0.00 0.222 0
Bacterial
Mortality***
0.792 0.64 1.0 0.372 0.957 0.00 0.647 0.424
Note: The Abbreviations are: Ab, A. baumannii; Ec, E. coli;H i ,H. influenzae; Kp, K. pneumoniae;P a ,P. aeruginosa; Sa, S. aureus;S m ,S. maltophilia; and Sp, S. pneumonia.
*indicates the number of patients whose positive culture was confirmed by one of the 4 culture-based tests.
**indicate confirmation rate of the positive cultures by one of the 4 culture-based tests.
***indicate the bacterial mortality due to refrigeration, storage, and transportation.
doi:10.1371/journal.pone.0038743.t001
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38743in clinical practice. The discrepancies essentially arise from their
different detecting objects. For DNA-based methods, on the one
hand,the targetsfordetectionarerepresentativesequencesfromthe
pathogens, alive or dead. Culture-based assays, on the other hand,
detectalllivingbacterialcellsgrowninthemedium.Certainly,there
are more elements and factors to be considered when culture-based
assays are to be performed, such as how to keep the cells alive and
what selective media to use for visualizing the colonies. Therefore,
statistic tools are of importance for dealing with the culture results.
We indeed used logistic curve to describe the probability of a
pathogentobepositiveincultureandthetiterofthe pathogenpanel
to be detected in order to reduce ambiguity of the culture-based
assays. The stochastic nature of the culture results can be both false
negative, where inoculated bacteria become dead in the lengthy
culturing process, and false positive, where bacteria are contami-
nants from the normal pharyngeal flora.
Figure 3. Examples of S. pneumonia showing the relationship between qLAMP and culture results (logistic regression) and cutoff
determination based on competitive relationship (piece-wise linear regression). The horizontal axis displays the bacterial natural
logarithmic titer in sputum sample. (A) Logistic regression curve (green line). Solid circles indicate patients; they are placed at the top of the chart
when being test as positive and at the bottom of the chart when being tested as negative in the culture assays. The height and width of the bars
display the frequency and the number of patients being tested positive in cultures, respectively. (B) Piecewise linear regression (black lines) of S.
pneumonia in COPD patients. Open circles indicate patients; they are placed at the top of the chart when being PC (Pathogen Candidate) and at the
bottom of the chart when NOT being PC.
doi:10.1371/journal.pone.0038743.g003
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38743Sensitivity and specificity are two of the most important factors
for evaluating new diagnostic tests. They are often used when a
gold standard or composite reference with high sensitivity and
specificity exits. [23] However, in our cases, culture test is the only
other available reference, and it cannot be regarded as an ideal
reference for determining the accuracy of qLAMP since it often
produces stochastic results. In addition, we cannot apply any
composite reference standard [24] due to unavailability of other
reference tests aside from bacterial cultures, because blood cultures
have even poorer positive rates, often less than 2% in Chinese
populations [15] (including Hong Kong [25]). In our study, the
well converged logistic regression demonstrates that qLAMP can
detect target sequence rather stably and thus shows good reliability
in bacterial titer quantification.
Figure 4. The percentage of bacteria identified as definite (dark blue) and possible (light blue) causative agents in LRTI patients (for
the full bacterial names see the legend of Figure 2). The patients are classified as: children, #14 yr; middle-aged adult, .14 yr but ,70 yr;
aged, $70 yr; AB, acute bronchitis; CAP, community acquired pneumonia; AECOPD, acute exacerbation of COPD; and AEBX, acute exacerbation of
bronchiectasis.
doi:10.1371/journal.pone.0038743.g004
Figure 5. The qLAMP-based diagnostic rates in LRTI patients and different subgroups.
doi:10.1371/journal.pone.0038743.g005
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PLoS ONE | www.plosone.org 9 June 2012 | Volume 7 | Issue 6 | e38743Statistical Methods are of Essence in Determining Cut-
offs Based on the Competitive Relationship among
Bacterial Pathogens
It is always a challenge to differentiate causative pathogens from
the pharyngeal flora that can be both ‘‘latent’’ and ‘‘contaminat-
ed’’. To make our DNA-based assay applicable to clinical settings,
we have to filter out the influence of contaminations from the
normal pharyngeal flora by setting rational cutoff values, or simply
cutoffs, between causative and latent bacteria. To take the
advantage of competitive relationships among pathogens, we
assume that for a pathogen to become dominant it must go
through a process from latency to dominance. Practically, we
choose cutoffs for the different phases in the process, where the
competitive relationship changes the most. Hundreds of microbial
species inhabit in our pharynx, forming a changing yet complex
microflora [26]. We made a few assumptions here. First, we
assume that there is homeostasis in the entire microecosystem that
lives through the host mucosal immunity, where all the microbial
inhabitants form an interaction network to prevent a alien species
from becoming dominant. [27–29] Second, we believe that under
normal circumstances the pathogens are also controlled under
seemingly normal conditions and do not have any more
competitive or inhibitory effects over other microbial species. As
a result, the pathogens are all in a latent or lag phase.
Subsequently, when conditions are changed to be more suitable
for one bacterial species over others, it may break the limit and
propagate abnormally or start to inhibit the propagation of other
species, and we say that the pathogen is in its log phase for fast
growth. At the end, when the bacteria become dominant and
destined to be pathogenic (dominant phase), the homeostasis of the
microflora is totally destroyed and the inhibitory effect reaches its
plateau. Therefore, third, we assume that cutoffs can be
determined to separate latent and causative pathogens from
breakpoints where pathogens escape from the control of host
immunity and become fixed, showing characteristics of infection.
The breakpoint where a specific bacterial pathogen overcomes
the host immunity control is determined by the stability of its niche
in pharynx. [30] Although both the components and their
abundances in the microflora vary among individuals, indicators,
such as the diversity of the whole microbiome, can be studied and
described in molecular terms within human populations. [31,32]
Therefore, we can assume that patients from the same subgroup
should share pharyngeal microecosystems or at least the properties
of their flora and thus share similar breakpoints as well. This
assumptionissupportedbyourobservations.Forinstance,whenthe
regression curves do not converge well, the breakpoints are often
heterogeneous over stratified populations or subgroups. In other
words, the rational stratification of populations or patients should
improve convergence and the shared cutoffs among similar
populations added a footnote to this notion.
The Cutoffs Derived from Piecewise Linear Regress has
Clinical Implications
The cutoffs derived from piecewise linear regression provide
information for clinical treatments. For instance, if a titer
determined based on qLAMP is above the upper cutoff, the
bacterium is considered to be the causative pathogen of the
infection, and relevant antibiotics should be prescribed. If the titer is
below the lower cutoff, the bacterium is considered to be normal
colonized status in the host and antibiotic treatment is deemed
unnecessary. If the titer falls between the two cutoffs, the bacterium
is possible to be involved in causing infection and should be cared
for by selecting an appropriate antibiotic treatment.
Although determining cutoffs for the differentiation of causative
pathogens from normal flora in sputum samples is highly desirable
in the etiological diagnosis of LRTI, it cannot be easily obtained
based on routine statistical methods due to the lack of sputum
samples from a legitimate control group. In our study, this problem
is overcome by using statistic tools based on the competitive nature
of bacterial pathogens and their growth characteristics when
becoming pathogenic. It can be applied in cases that meet the
following conditions. First, quantitative data for multiple pathogens
are available. Second, competitive relationship among the panel of
pathogens is unbiased. Third, the trial size is large enough to resist
stochastic factors. Therefore, cutoffs for pathogens can be deduced,
regardless if the pathogens can be cultured or not, based on the
statistic methods as long as they exhibit both latent and pathogenic
phases in the host pharyngeal flora.
Cautions
Some bacterial species in our study show somewhat higher rates
as causative agents than expected. The reasons may fall into either
or both of the following categories. First, the target genes selected or
primers designed are not conserved enough or optimized enough to
have satisfactory sensitivity and specificity to be accurately
quantified. Second, the subjects in our study are all in-patients
and their symptoms are somewhat more severe than what often
observed in common CAP and AECOPD patients. It should also be
mentioned that the number of patients in our study is rather limited
when the data are stratified into subgroups. Therefore, we noticed
heterogeneity in breakpoints in the same patient subgroup, which
affects the accuracy in deducing cutoffs. However, this last caution
can be eliminated by increasing the cohort size, and implementing
better experimental designs in future studies.
Conclusion
In conclusion, we demonstrated that qLAMP assay (and perhaps
other quantitative DNA-based methods) is a reliable method for the
quantification of pathogens in sputum samples, especially when
statistical analyses based on competitive relationships among
bacteria are appropriately applied to determine thresholds where
pathogens can overcome them and become pathogenic afterwards.
These thresholds can also serve as cutoffs to filter out influence of
contaminants from the pharyngeal flora to make qLAMP as
quantitative methods practical in clinical etiologic diagnosis. We
believe that quantitative DNA-based assays will make important
contributions in the future to the clinical identification of pathogens,
including bacteria, non-classical pathogens, and fungi, especially in
the present time when pathogens are more complex than before,
andsomeofthemarenot onlypresentlyunknownbutalsonot easily
identified based on the routine culture methods.
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